These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12170258)

  • 41. Tetramer-Guided Epitope Mapping: A Rapid Approach to Identify HLA-Restricted T-Cell Epitopes from Composite Allergens.
    Archila LL; Kwok WW
    Methods Mol Biol; 2017; 1592():199-209. PubMed ID: 28315222
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Luminal bacterial antigen-specific CD4+ T-cell responses in HLA-B27 transgenic rats with chronic colitis are mediated by both major histocompatibility class II and HLA-B27 molecules.
    Qian BF; Tonkonogy SL; Balfour Sartor R
    Immunology; 2006 Mar; 117(3):319-28. PubMed ID: 16476051
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mapping and restriction of a dominant viral CD4+ T cell core epitope by both MHC class I and MHC class II.
    Homann D; Lewicki H; Brooks D; Eberlein J; Mallet-Designé V; Teyton L; Oldstone MB
    Virology; 2007 Jun; 363(1):113-23. PubMed ID: 17320138
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Attenuated Listeria monocytogenes carrier strains can deliver an HIV-1 gp120 T helper epitope to MHC class II-restricted human CD4+ T cells.
    Guzmán CA; Saverino D; Medina E; Fenoglio D; Gerstel B; Merlo A; Li Pira G; Buffa F; Chakraborty T; Manca F
    Eur J Immunol; 1998 Jun; 28(6):1807-14. PubMed ID: 9645361
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficient delivery of T cell epitopes to APC by use of MHC class II-specific Troybodies.
    Lunde E; Western KH; Rasmussen IB; Sandlie I; Bogen B
    J Immunol; 2002 Mar; 168(5):2154-62. PubMed ID: 11859101
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Melanoma-specific CD4+ T lymphocytes recognize human melanoma antigens processed and presented by Epstein-Barr virus-transformed B cells.
    Topalian SL; Rivoltini L; Mancini M; Ng J; Hartzman RJ; Rosenberg SA
    Int J Cancer; 1994 Jul; 58(1):69-79. PubMed ID: 7516926
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide.
    Bonehill A; Heirman C; Tuyaerts S; Michiels A; Zhang Y; van der Bruggen P; Thielemans K
    Cancer Res; 2003 Sep; 63(17):5587-94. PubMed ID: 14500399
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MHC class II tetramer guided detection of Mycobacterium tuberculosis-specific CD4+ T cells in peripheral blood from patients with pulmonary tuberculosis.
    Höhn H; Kortsik C; Zehbe I; Hitzler WE; Kayser K; Freitag K; Neukirch C; Andersen P; Doherty TM; Maeurer M
    Scand J Immunol; 2007 May; 65(5):467-78. PubMed ID: 17444958
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fluorescent target array T helper assay: a multiplex flow cytometry assay to measure antigen-specific CD4+ T cell-mediated B cell help in vivo.
    Quah BJ; Wijesundara DK; Ranasinghe C; Parish CR
    J Immunol Methods; 2013 Jan; 387(1-2):181-90. PubMed ID: 23123200
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of HLA class II-restricted H-Y-specific T-helper epitope evoking CD4+ T-helper cells in H-Y-mismatched transplantation.
    Spierings E; Vermeulen CJ; Vogt MH; Doerner LE; Falkenburg JH; Mutis T; Goulmy E
    Lancet; 2003 Aug; 362(9384):610-5. PubMed ID: 12944060
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A population response analysis approach to assign class II HLA-epitope restrictions.
    Paul S; Dillon MBC; Arlehamn CSL; Huang H; Davis MM; McKinney DM; Scriba TJ; Sidney J; Peters B; Sette A
    J Immunol; 2015 Jun; 194(12):6164-6176. PubMed ID: 25948811
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantification of HLA-DM-Dependent Major Histocompatibility Complex of Class II Immunopeptidomes by the Peptide Landscape Antigenic Epitope Alignment Utility.
    Álvaro-Benito M; Morrison E; Abualrous ET; Kuropka B; Freund C
    Front Immunol; 2018; 9():872. PubMed ID: 29774024
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tumor-specific CD4+ T cells are activated by "cross-dressed" dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines.
    Dolan BP; Gibbs KD; Ostrand-Rosenberg S
    J Immunol; 2006 Feb; 176(3):1447-55. PubMed ID: 16424172
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sequence conservation analysis and in silico human leukocyte antigen-peptide binding predictions for the Mtb72F and M72 tuberculosis candidate vaccine antigens.
    Mortier MC; Jongert E; Mettens P; Ruelle JL
    BMC Immunol; 2015 Oct; 16():63. PubMed ID: 26493839
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Limited role for CD4+ T-cell help in the initial priming of Trypanosoma cruzi-specific CD8+ T cells.
    Padilla A; Xu D; Martin D; Tarleton R
    Infect Immun; 2007 Jan; 75(1):231-5. PubMed ID: 17043105
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modified vaccinia virus Ankara-infected dendritic cells present CD4+ T-cell epitopes by endogenous major histocompatibility complex class II presentation pathways.
    Thiele F; Tao S; Zhang Y; Muschaweckh A; Zollmann T; Protzer U; Abele R; Drexler I
    J Virol; 2015 Mar; 89(5):2698-709. PubMed ID: 25520512
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HLA tetramers and anti-CMV immune responses: from epitope to immunotherapy.
    Chen FE; Aubert G; Travers P; Dodi IA; Madrigal JA
    Cytotherapy; 2002; 4(1):41-8. PubMed ID: 11953040
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MHC class II-associated invariant chain peptide replacement by T cell epitopes: engineered invariant chain as a vehicle for directed and enhanced MHC class II antigen processing and presentation.
    Malcherek G; Wirblich C; Willcox N; Rammensee HG; Trowsdale J; Melms A
    Eur J Immunol; 1998 May; 28(5):1524-33. PubMed ID: 9603457
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation.
    Wälchli S; Kumari S; Fallang LE; Sand KM; Yang W; Landsverk OJ; Bakke O; Olweus J; Gregers TF
    Eur J Immunol; 2014 Mar; 44(3):774-84. PubMed ID: 24293164
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of a mutated receptor-like protein tyrosine phosphatase kappa as a novel, class II HLA-restricted melanoma antigen.
    Novellino L; Renkvist N; Rini F; Mazzocchi A; Rivoltini L; Greco A; Deho P; Squarcina P; Robbins PF; Parmiani G; Castelli C
    J Immunol; 2003 Jun; 170(12):6363-70. PubMed ID: 12794170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.